RenaissanceRe Holdings Ltd. (RNR) AI Stock Analysis

NYSE: RNRAI research summary: business, growth, valuation, analysts, bull and bear case.

RNR AI stock analysis summary

AI Research

RenaissanceRe Holdings Ltd. (RNR) is a global provider of reinsurance and insurance products across property, casualty, and specialty lines. The company delivered $12.75B in revenue and $2.68B in net income in FY2025, supported by a 5-year revenue CAGR of 19.9%. However, revenue contracted 13.2% year-over-year in the quarter ended June 30, 2026.

Market cap
$14.59B
Revenue (TTM)
$11.17B
P/E
6.1x
fwd 8.1x
1Y return
40.1%
S&P 500 16.8%
Avg. target
$347.31
-1.1% vs last close

Bull case

  • The company maintains a strong balance sheet with $5.25B in cash and short-term investments and a net cash position of $2.92B as of June 30, 2026.
  • Valuation multiples remain discounted relative to the sector, with a forward P/E of 8.1x compared to the US-listed Financial Services median of 10.8x.
  • RenaissanceRe generated $3.69B in free cash flow in FY2025, funding $1.60B in share buybacks and reducing its 5-year share count by 7.2%.

Bear case

  • Quarterly revenue fell 13.2% year-over-year in the period ended June 30, 2026, alongside a 10.0% decline in quarterly earnings.
  • Full-year revenue estimates project a drop from $12.75B in FY2025 to $8.15B in FY2026 and $8.04B in FY2027.
  • Wall Street sentiment is tempered, with the mean price target of $347.31 sitting 1.1% below the last closing price of $351.06.

What RenaissanceRe does

RenaissanceRe Holdings Ltd., founded in 1993 and headquartered in Pembroke, Bermuda, provides reinsurance and insurance products worldwide. It operates through two segments: Property, and Casualty and Specialty. The Property segment offers catastrophe excess of loss reinsurance and retrocessional reinsurance, protecting insurers against natural and man-made disasters including hurricanes, earthquakes, typhoons, floods, and terrorism. The Casualty and Specialty segment provides diverse coverages such as directors and officers liability, cyber, medical malpractice, professional indemnity, and trade credit. RenaissanceRe distributes products mainly through intermediaries and also operates an investment management business managing funds.

Growth and profitability

RenaissanceRe increased revenue from $5.27B in FY2021 to $12.75B in FY2025, achieving a 5-year revenue CAGR of 19.9%. Net income recovered from -$1.06B in FY2022 to $2.56B in FY2023 and reached $2.68B in FY2025, alongside an operating margin of 31.5% and a net margin of 21.0%. Over the trailing twelve months, revenue totaled $11.17B with an operating margin of 41.7% and EPS of $57.91. For the quarter ended June 30, 2026, quarterly revenue fell 13.2% year-over-year and quarterly earnings decreased 10.0%.

RNR income statement →

Balance sheet and cash flow

As of June 30, 2026, the company held $5.25B in cash and short-term investments against $2.33B in total debt, creating a net cash position of $2.92B. Shareholders' equity was $11.82B against total assets of $55.20B, yielding a debt-to-equity ratio of 0.20 and a current ratio of 1.76. In FY2025, operating cash flow and free cash flow both reached $3.69B. Capital returns in FY2025 included $1.60B in share buybacks and $110.2M in dividends paid, contributing to a 5-year share count decline of 7.2%.

RNR balance sheet →

Valuation and performance

At $351.06, RenaissanceRe trades at a trailing P/E of 6.1x and a forward P/E of 8.1x, below the US-listed Financial Services median of 12.1x trailing and 10.8x forward. Its price-to-sales multiple is 1.3x versus the peer median of 3.2x, while EV/revenue sits at 1.4x and price-to-book is 1.2x. Over the past year, RNR gained 40.1% compared to a 16.8% return for the S&P 500. Over 5 years, the stock returned 146.2% versus 83.0% for the S&P 500.

RNR key metrics →

RNR dividend

RenaissanceRe pays a quarterly dividend with an annualized forward rate of $1.64 per share, translating to a dividend yield of 0.47%. The payout ratio is 2.9%, and the company has paid dividends for 32 consecutive years. The dividend grew at an annualized rate of 2.7% over the past 5 years. Its last ex-dividend date was September 15, 2026.

RNR dividend history →

What analysts expect

Wall Street analysts hold 4 Strong Buy, 13 Hold, and 1 Strong Sell recommendations on RNR. The mean price target is $347.31, which is 1.1% below the last close of $351.06. For the current fiscal year ending December 31, 2026, consensus estimates project revenue of $8.15B and EPS of $46.62, representing 19.2% EPS growth. RenaissanceRe has beaten EPS estimates in each of the last 4 quarters, and its next earnings date is October 27, 2026.

RNR forecast and price target →

Key risks and what to watch

  • Underwriting results can fluctuate substantially, as demonstrated by net income swinging from -$1.06B in FY2022 to $2.56B in FY2023.
  • Revenue contraction in the latest quarter ended June 30, 2026, with revenue down 13.2% year-over-year, indicates near-term top-line softening.
  • Consensus forecasts model further revenue contraction to $8.04B in FY2027, representing a 1.3% decline from FY2026 expectations.

AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer

About this RNR AI stock analysis

This page is an AI-written research summary of RenaissanceRe Holdings Ltd. (RNR). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: RNR income statement, RNR balance sheet, RNR key metrics, RNR analyst forecast, RNR chart. See the RNR stock overview for the latest quote and news.

RNR AI stock analysis FAQ

What is RenaissanceRe's dividend yield and track record?

RenaissanceRe offers a forward annual dividend of $1.64 per share, which equals a 0.47% dividend yield. The company has paid dividends for 32 consecutive years and maintains a payout ratio of 2.9%.

How did RenaissanceRe perform financially in FY2025?

In FY2025, RenaissanceRe generated $12.75B in revenue, representing 9.4% growth year-over-year. Net income was $2.68B with an operating margin of 31.5% and free cash flow of $3.69B.

What is RenaissanceRe's valuation compared to peers?

RenaissanceRe trades at a trailing P/E of 6.1x and a forward P/E of 8.1x, compared to the US-listed Financial Services medians of 12.1x and 10.8x, respectively. Its price-to-sales ratio is 1.3x versus the peer median of 3.2x.

When does RenaissanceRe report its next earnings?

The company's next earnings report is scheduled for October 27, 2026. RenaissanceRe has beaten EPS estimates in all of the last 4 quarters.

More Financial Services AI stock analysis